Get the Stockscreener App
4.41
7.04%
0.29
After Hours:
4.40
-0.010
-0.23%
Neuphoria Therapeutics Inc stock is traded at $4.41, with a volume of 62,916.
It is up +7.04% in the last 24 hours and up +3.52% over the past month.
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.
See More
Previous Close:
$4.12
Open:
$4.139
24h Volume:
62,916
Relative Volume:
1.27
Market Cap:
$23.77M
Revenue:
$15.66M
Net Income/Loss:
$1.28M
P/E Ratio:
33.38
EPS:
0.1321
Net Cash Flow:
$-2.28M
1W Performance:
+5.00%
1M Performance:
+3.52%
6M Performance:
-69.88%
1Y Performance:
-23.97%
1-Day Range:
$4.0697
$4.46
1-Week Range:
$3.84
$4.50
52-Week Range:
$3.645
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Name
Neuphoria Therapeutics Inc
Sector
Industry
Phone
781-439-5551
Address
100 SUMMIT DR, BURLINGTON
Compare NEUP vs VRTX, REGN, ARGX, ALNY, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
4.41 | 23.77M | 15.66M | 1.28M | -2.28M | 0.1321 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-23 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-28-23 | Reiterated | Maxim Group | Buy |
| Jan-10-22 | Initiated | Berenberg | Buy |
| Jan-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-10-22 | Initiated | Evercore ISI | Outperform |
| Jan-10-22 | Initiated | H.C. Wainwright | Buy |
View All
Neuphoria Therapeutics Inc Stock (NEUP) Latest News
If You Invested $1,000 in Neuphoria Therapeutics Inc (NEUP) - Stock Titan
Fed Watch: Whats the outlook for Neuphoria Therapeutics Incs sectorQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Aug Outlook: Is Neuphoria Therapeutics Inc a good ESG investment2026 Bull vs Bear & Daily Stock Momentum Reports - baoquankhu1.vn
NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition - MSN
Bull Run: What is the PEG ratio of Neuphoria Therapeutics Inc2026 Big Picture & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Neuphoria Therapeutics Inc. (NEUP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
NEUP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aug Mood: What is the PEG ratio of Neuphoria Therapeutics IncWeekly Trend Report & Low Volatility Stock Suggestions - baoquankhu1.vn
History Review: Can Neuphoria Therapeutics Inc beat the S P 500Weekly Earnings Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Volatility Watch: Is Neuphoria Therapeutics Inc impacted by rising rates2026 Buyback Activity & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Neuphoria Therapeutics Inc. (NASDAQ:NEUP) Short Interest Down 56.8% in February - Defense World
Big Picture: Can Neuphoria Therapeutics Inc. stock double in the next year2026 Support & Resistance & Technical Pattern Recognition Alerts - baoquankhu1.vn
Short Squeeze: What is Neuphoria Therapeutics Incs P E ratio telling us2025 Trading Volume Trends & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Aug Outlook: Can Neuphoria Therapeutics Inc maintain sales growthQuarterly Growth Report & Verified Entry Point Detection - baoquankhu1.vn
Can Neuphoria Therapeutics Inc maintain sales growthJuly 2025 Intraday Action & High Conviction Buy Zone Alerts - baoquankhu1.vn
Why Did NEUP Stock Surge 64% Today? - Stocktwits
Critical Analysis: Immunic (NASDAQ:IMUX) and Neuphoria Therapeutics (NASDAQ:NEUP) - Defense World
Head to Head Review: Neuphoria Therapeutics and Immunic - National Today
BNOX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Here's Why We're Not At All Concerned With Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation - Yahoo Finance
Neuphoria Therapeutics Inc. SEC 10-Q Report - TradingView
Neuphoria Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2025 - marketscreener.com
Is Neuphoria Therapeutics Inc. impacted by rising ratesJuly 2025 Final Week & High Conviction Investment Ideas - mfd.ru
Can Neuphoria Therapeutics Inc. outperform in the next rally2025 Price Momentum & Daily Chart Pattern Signal Reports - mfd.ru
Pharma News: Should you buy the dip on Wachovia Capital Trust IX Preferred SecurityMarket Movement Recap & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Wall Street Recap: Whats the outlook for Neuphoria Therapeutics Incs sectorPortfolio Gains Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Exit Recap: What is the implied volatility of Lakeland Financial CorporationMarket Trend Report & Weekly Chart Analysis and Guides - baoquankhu1.vn
Neuphoria receives $15M milestone payment from Merck - MSN
Market Wrap: Will Neuphoria Therapeutics Inc outperform during market ralliesEarnings Risk Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Will Neuphoria Therapeutics Inc stock outperform value stocksStock Surge & Stepwise Entry/Exit Trade Alerts - Bộ Nội Vụ
Neuphoria Shares Climb 4% After Launching Strategic Review to Enhance Shareholder Value - MSN
Why Neuphoria Therapeutics Inc. stock could outperform in 2025Inflation Watch & Stock Timing and Entry Methods - ulpravda.ru
Neuphoria Therapeutics Inc.Common Stock (NQ: NEUP - FinancialContent
Ford, Intel, AMD, Neuphoria Therapeutics, Deckers Outdoor: Stocks Making The Biggest Moves Today - MSN
Will Neuphoria Therapeutics Inc. stock outperform Dow Jones indexBreathability and Upper Notes & lightweight options for faster days - Улправда
Neuphoria Therapeutics Announces CEO Transition and Consulting Role - The Globe and Mail
How strong is Neuphoria Therapeutics Inc. stock balance sheetMarket Trend Summary & High Accuracy Swing Entry Alerts - ulpravda.ru
What risks investors should watch in Neuphoria Therapeutics Inc. stock2025 Biggest Moves & Entry Point Strategy Guides - Улправда
Will Neuphoria Therapeutics Inc. stock see insider buyingMarket Trend Report & Stock Timing and Entry Methods - ulpravda.ru
Does Neuphoria Therapeutics Inc. stock trade at a discount to peers2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - ulpravda.ru
Can Neuphoria Therapeutics Inc. stock double in next 5 years2025 Valuation Update & Weekly High Potential Stock Alerts - Улправда
Will Neuphoria Therapeutics Inc. stock split again soon2025 Trading Volume Trends & Weekly Hot Stock Watchlists - Улправда
Growth Recap: How Neuphoria Therapeutics Inc. stock reacts to oil pricesTrade Analysis Summary & Proven Capital Preservation Methods - Улправда
How Neuphoria Therapeutics Inc. stock reacts to oil prices2025 Momentum Check & AI Forecasted Entry/Exit Points - Улправда
How Neuphoria Therapeutics Inc. stock benefits from tech adoptionWall Street Watch & Precise Swing Trade Alerts - Улправда
Setup Watch: How strong is Neuphoria Therapeutics Inc. stock balance sheet2025 Key Lessons & Real-Time Buy Signal Notifications - Улправда
Is Neuphoria Therapeutics Inc. stock trading near support levels2025 Analyst Calls & Verified Trade Idea Suggestions - ulpravda.ru
Neuphoria Therapeutics Inc. Announces Termination of Spyridon Papapetropoulos as CEO and Appointment as Interim CEO Effective December 31, 2025 - marketscreener.com
Neuphoria Therapeutics Inc Stock (NEUP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):